Recombinant Human DMT1 Protein，His

DMT1, or Divalent Metal Transporter 1, is a vital protein that facilitates the uptake of divalent metal ions, including iron, manganese, and cobalt, across cellular membranes. Its role is particularly crucial in maintaining metal homeostasis and preventing deficiencies or toxicities in cells. Dysregulation of DMT1 is associated with various pathological conditions, including anemia, neurodegenerative diseases, and iron overload disorders like hemochromatosis. Research on recombinant DMT1 has gained momentum as scientists aim to elucidate its structure-function relationships, regulatory mechanisms, and interactions with other cellular proteins. The recombinant expression of DMT1 in heterologous systems allows for detailed biochemical characterization and functional studies. By producing purified DMT1, researchers can investigate its transport kinetics, substrate specificity, and the effects of mutations linked to human diseases. Furthermore, understanding the molecular mechanisms governing DMT1 activity could pave the way for therapeutic strategies targeting metal ion dysregulation in diseases. Advancements in techniques such as X-ray crystallography and cryo-electron microscopy are expected to provide insights into the 3D structure of DMT1, enhancing our comprehension of how this transporter operates at the molecular level. Overall, the study of recombinant DMT1 is not only essential for basic biological understanding but also holds potential clinical implications for developing interventions in metal-related disorders.